Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$84.70 USD
-2.02 (-2.33%)
Updated May 13, 2024 04:00 PM ET
After-Market: $84.74 +0.04 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 40% (100 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.16 | 1.57 | 9.99 |
Current Quarter Estimate | 0.70 | 3.93 | 57.00 |
Year Ago Quarter Estimate | 0.66 | 3.85 | 52.54 |
Next Quarter Estimate | 0.69 | 3.92 | 61.00 |
Next Year Estimate | 3.11 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 10.36 | 14.00 | 15.67 |
Next Year | 12.27 | 22.20 | 9.31 |
Last 5 Years | 9.90 | 9.90 | 8.10 |
Next 5 Years | 8.60 | 14.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 34.01 | 29.13 |
Price/Book (MRQ) | 7.27 | 2.44 |
Price/Cash Flow (MRFY) | 31.39 | 15.17 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 23.01% | -4.54% |
Return on Equity (TTM) | 22.86% | -1.65% |
Debt to Equity (MRQ) | 0.08 | 27.03 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.